Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccines

被引：47

作者：

Earl, Patricia L. ^{[1
]}

Cotter, Catherine ^{[1
,2
]}

Moss, Bernard ^{[1
]}

VanCott, Thomas ^{[2
]}

Currier, Jeffrey ^{[2
]}

Eller, Leigh Anne ^{[2
]}

McCutchan, Francine ^{[2
]}

Birx, Deborah L. ^{[2
]}

Michael, Nelson L. ^{[2
]}

Marovich, Mary A. ^{[2
]}

Robb, Merlin ^{[2
]}

Earla, Patricia L. ^{[2
]}

机构：

[1] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA

[2] Walter Reed Army Inst Res, Mil HIV Res Program, Rockville, MD USA

来源：

VACCINE | 2009年 / 27卷 / 42期

关键词：

MVA; HIV vaccine; Immune response; HUMAN-IMMUNODEFICIENCY-VIRUS; IN-VITRO EXPRESSION; TYPE-1; SUBTYPE-C; T-CELL EPITOPES; ANKARA MVA; ENVELOPE GLYCOPROTEIN; IMMUNE-RESPONSES; RHESUS-MONKEYS; GAG-POL; PROTECTIVE IMMUNITY;

D O I：

10.1016/j.vaccine.2009.07.039

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Recombinant modified vaccinia virus Ankara (rMVA) expressing HIV-1 genes are promising vaccine candidates. Toward the goal of conducting clinical trials with one or a cocktail of recombinant viruses, four rMVAs expressing env and gag-pol genes from primary HIV-1 isolates representing predominant subtypes from Kenya, Tanzania, Uganda, and Thailand (A, C, D, and CRF01_AE, respectively) were constructed. Efficient expression, processing, and function of Env and Gag were demonstrated. All inserted genes were shown to be genetically stable after repeated passage in cell culture. Strong HIV-specific cellular and humoral immune responses were elicited in mice immunized with each individual vaccine candidate. The MVA/CMDR vaccine candidate expressing CRF01_AE genes has elicited HIV-specific T-cell responses in two independent Phase I clinical trials. Further testing of the other rMVA is warranted. Published by Elsevier Ltd.

引用

页码：5885 / 5895

页数：11

共 80 条

[1] CC CKRS: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1 [J].

Alkhatib, G ;

Combadiere, C ;

Broder, CC ;

Feng, Y ;

Kennedy, PE ;

Murphy, PM ;

Berger, EA .

SCIENCE, 1996, 272 (5270) :1955-1958

[2] Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine [J].

Amara, RR ;

Smith, JM ;

Staprans, SI ;

Montefiori, DC ;

Villinger, F ;

Altman, JD ;

O'Neil, SP ;

Kozyr, NL ;

Xu, Y ;

Wyatt, LS ;

Earl, PL ;

Herndon, JG ;

McNicholl, JM ;

McClure, HM ;

Moss, B ;

Robinson, HL .

JOURNAL OF VIROLOGY, 2002, 76 (12) :6138-6146

[3] Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine [J].

Amara, RR ;

Villinger, F ;

Altman, JD ;

Lydy, SL ;

O'Neil, SP ;

Staprans, SI ;

Montefiori, DC ;

Xu, Y ;

Herndon, JG ;

Wyatt, LS ;

Candido, MA ;

Kozyr, NL ;

Earl, PL ;

Smith, JM ;

Ma, HL ;

Grimm, BD ;

Hulsey, ML ;

Miller, J ;

McClure, HM ;

McNicholl, JM ;

Moss, B ;

Robinson, HL .

SCIENCE, 2001, 292 (5514) :69-74

[4] Different patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines [J].

Amara, RR ;

Villinger, F ;

Staprans, SI ;

Altman, JD ;

Montefiori, DC ;

Kozyr, NL ;

Xu, Y ;

Wyatt, LS ;

Earl, PL ;

Herndon, JG ;

McClure, HM ;

Moss, B ;

Robinson, HL .

JOURNAL OF VIROLOGY, 2002, 76 (15) :7625-7631

[5] The complete genomic sequence of the modified vaccinia Ankara strain: Comparison with other orthopoxviruses [J].

Antoine, G ;

Scheiflinger, F ;

Dorner, F ;

Falkner, FG .

VIROLOGY, 1998, 244 (02) :365-396

[6] HIV type 1 subtypes among blood donors in the Mbeya region of southwest Tanzania [J].

Arroyo, MA ;

Hoelscher, M ;

Sanders-Buell, E ;

Herbinger, KH ;

Samky, E ;

Maboko, L ;

Hoffmann, O ;

Robb, MR ;

Birx, DL ;

McCutchan, FE .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 2004, 20 (08) :895-901

[7]

BAKARI M, 2008, SAFETY IMMUNOGENICIT

[8] Challenges in the development of an HIV-1 vaccine [J].

Barouch, Dan H. .

NATURE, 2008, 455 (7213) :613-619

[9] Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination [J].

Barouch, DH ;

Santra, S ;

Kuroda, MJ ;

Schmitz, JE ;

Plishka, R ;

Buckler-White, A ;

Gaitan, AE ;

Zin, R ;

Nam, JH ;

Wyatt, LS ;

Lifton, MA ;

Nickerson, CE ;

Moss, B ;

Montefiori, DC ;

Hirsch, VM ;

Letvin, NL .

JOURNAL OF VIROLOGY, 2001, 75 (11) :5151-5158

[10] HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells [J].

Betts, Michael R. ;

Nason, Martha C. ;

West, Sadie M. ;

De Rosa, Stephen C. ;

Migueles, Stephen A. ;

Abraham, Jonathan ;

Lederman, Michael M. ;

Benito, Jose M. ;

Goepfert, Paul A. ;

Connors, Mark ;

Roederer, Mario ;

Koup, Richard A. .

BLOOD, 2006, 107 (12) :4781-4789

← 1 2 3 4 5 6 7 8 →